The use of EBV‐transformed cell lines of breast cancer patients to measure chromosomal radiosensitivity

By Baeyens A.  

Mutagenesis, Vol. 19, Iss. 4, 2004-07 ,pp. : 285-290

Oxford University Press

Access to resources Recommend Favorite

G 2 checkpoint control and G 2 chromosomal radiosensitivity in cancer survivors and their families

By Cadwell Kevin K.   Curwen Gillian B.   Tawn E. Janet   Winther Jeanette F.   Boice John D.  

Mutagenesis, Vol. 26, Iss. 2, 2011-03 ,pp. : 291-294

Oxford University Press

Access to resources Recommend Favorite

Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer

By Bryant Peter E.  

Mutagenesis, Vol. 27, Iss. 6, 2012-11 ,pp. : 737-741

Oxford University Press

Access to resources Recommend Favorite

Cyclooxygenase-2 and chemoprevention of breast cancer

By Davies G.L.S.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite

Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer

By Michalaki V.   Koutroulis G.   Koutroulis G.   Syrigos K.   Piperi C.   Kalofoutis A.  

Molecular and Cellular Biochemistry, Vol. 268, Iss. 1-2, 2005-01 ,pp. : 19-24

Springer Publishing Company

Access to resources Recommend Favorite